妊娠期高血压疾病与未来心血管疾病的关联
本研究采用孟德尔随机化方法,利用FinnGen联盟女性特异性汇总数据,以非相关的单核苷酸变异作为工具变量,分析遗传预测的妊娠期高血压疾病(包括妊娠期高血压和子痫前期/子痫)与冠心病、缺血性卒中、心力衰竭和心房颤动的关联。结果显示,遗传预测的妊娠期高血压疾病与冠心病风险升高相关(OR 1.24,95%CI 1.08-1.43,P=0.002),与缺血性卒中风险升高相关(OR 1.27,95%CI 1.12-1.44,P=2.87×10⁻⁴),但与心力衰竭和心房颤动无显著关联。中介分析显示,收缩压和2型糖尿病部分介导了妊娠期高血压疾病对冠心病的影响。结论支持将妊娠期高血压疾病归类为心血管疾病危险因素。
要点
- 遗传预测的妊娠期高血压疾病与冠心病风险升高相关(OR 1.24,95%CI 1.08-1.43,P=0.002)。
- 遗传预测的妊娠期高血压疾病与缺血性卒中风险升高相关(OR 1.27,95%CI 1.12-1.44,P=2.87×10⁻⁴)。
- 遗传预测的妊娠期高血压疾病与心力衰竭(OR 0.97,95%CI 0.76-1.23,P=0.79)和心房颤动(OR 1.11,95%CI 0.65-1.88,P=0.71)无显著关联。
- 收缩压和2型糖尿病部分介导了妊娠期高血压疾病对冠心病的影响。
- 研究支持将妊娠期高血压疾病归类为心血管疾病危险因素。
适用人群与场景
- 研究纳入的患者主要为欧洲血统。
- 暴露数据来自FinnGen联盟(第六版发布)的女性特异性汇总数据。
- 结局数据来自全基因组关联研究:冠心病122,733例、缺血性卒中34,217例、心力衰竭47,309例、心房颤动60,620例。
研究设计与关键结果
- 研究设计:全基因组遗传关联研究,采用孟德尔随机化(MR),于2022年2月16日至2022年3月4日进行。
- 主要分析采用逆方差加权MR;中介分析采用多变量MR框架。
- 遗传预测的妊娠期高血压疾病与冠心病风险升高相关(OR 1.24,95%CI 1.08-1.43,P=0.002);该关联在妊娠期高血压(OR 1.08,95%CI 1.00-1.17,P=0.04)和子痫前期/子痫(OR 1.06,95%CI 1.01-1.12,P=0.03)中均可见。
- 遗传预测的妊娠期高血压疾病与缺血性卒中风险升高相关(OR 1.27,95%CI 1.12-1.44,P=2.87×10⁻⁴)。
- 中介分析显示,校正收缩压后,妊娠期高血压疾病对冠心病的影响部分减弱(总效应OR 1.24;直接效应OR 1.10;95%CI 1.02-1.08;P=0.02);校正2型糖尿病后亦部分减弱(总效应OR 1.24;直接效应OR 1.16;95%CI 1.04-1.29;P=0.008)。
- 遗传预测的妊娠期高血压疾病与心力衰竭(OR 0.97,95%CI 0.76-1.23,P=0.79)或心房颤动(OR 1.11,95%CI 0.65-1.88,P=0.71)无显著关联。
证据类型、等级与局限
- 证据类型:全基因组遗传关联研究(孟德尔随机化)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 研究结论支持将妊娠期高血压疾病归类为心血管疾病危险因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONCLUSIONS AND RELEVANCE: The findings of this study provide genetic evidence supporting an association between HDPs and higher risk of coronary artery disease and stroke, which is only partially mediated by cardiometabolic factors. This supports classification of HDPs as risk factors for cardiovascular disease.
DESIGN, SETTING, AND PARTICIPANTS: A genome-wide genetic association study using mendelian randomization (MR) was performed from February 16 to March 4, 2022. Primary analysis was conducted using inverse-variance-weighted MR. Mediation analyses were performed using a multivariable MR framework. All studies included patients predominantly of European ancestry. Female-specific summary-level data from FinnGen (sixth release).
EXPOSURES: Uncorrelated (r2<0.001) single-nucleotide variants (SNVs) were selected as instrumental variants from the FinnGen consortium summary statistics for exposures of any HDP, gestational hypertension, and preeclampsia or eclampsia.
IMPORTANCE: Hypertensive disorders in pregnancy (HDPs) are major causes of maternal and fetal morbidity and are observationally associated with future maternal risk of cardiovascular disease. However, observational results may be subject to residual confounding and bias.
MAIN OUTCOMES AND MEASURES: Genetic association estimates for outcomes were extracted from genome-wide association studies of 122 733 cases for coronary artery disease, 34 217 cases for ischemic stroke, 47 309 cases for heart failure, and 60 620 cases for atrial fibrillation.
OBJECTIVE: To investigate the association of HDPs with multiple cardiovascular diseases.
RESULTS: Genetically predicted HDPs were associated with a higher risk of coronary artery disease (odds ratio [OR], 1.24; 95% CI, 1.08-1.43; P = .002); this association was evident for both gestational hypertension (OR, 1.08; 95% CI, 1.00-1.17; P = .04) and preeclampsia/eclampsia (OR, 1.06; 95% CI, 1.01-1.12; P = .03). Genetically predicted HDPs were also associated with a higher risk of ischemic stroke (OR, 1.27; 95% CI, 1.12-1.44; P = 2.87 × 10-4). Mediation analysis revealed a partial attenuation of the effect of HDPs on coronary artery disease after adjustment for systolic blood pressure (total effect OR, 1.24; direct effect OR, 1.10; 95% CI, 1.02-1.08; P = .02) and type 2 diabetes (total effect OR, 1.24; direct effect OR, 1.16; 95% CI, 1.04-1.29; P = .008). No associations were noted between genetically predicted HDPs and heart failure (OR, 0.97; 95% CI, 0.76-1.23; P = .79) or atrial fibrillation (OR, 1.11; 95% CI, 0.65-1.88; P = .71).
参考来源
- Rayes B, Ardissino M, Slob EAW, et al. Association of Hypertensive Disorders of Pregnancy With Future Cardiovascular Disease. JAMA Netw Open. 2023. PMID: 36800181. doi:10.1001/jamanetworkopen.2023.0034
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。